News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chen Bihua
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 58,839 shares
@ $59.8973, valued at
$3.5M
|
|
| 10/04/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 74,911 shares
@ $57.37, valued at
$4.3M
Bought 150,487 shares
@ $57.252, valued at
$8.6M
Bought 67,814 shares
@ $57.3188, valued at
$3.9M
|
|
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 800,000 shares
@ $50, valued at
$40M
|
|
| 06/28/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 1,481 shares
@ $36.91, valued at
$54.7k
Bought 3,755 shares
@ $38.18, valued at
$143.4k
Bought 10,593 shares
@ $39.17, valued at
$414.9k
Bought 38,623 shares
@ $39.87, valued at
$1.5M
Bought 50,642 shares
@ $41.03, valued at
$2.1M
Bought 61,042 shares
@ $42.12, valued at
$2.6M
Bought 66,087 shares
@ $43.3, valued at
$2.9M
Bought 31,558 shares
@ $44.23, valued at
$1.4M
Bought 10,946 shares
@ $44.93, valued at
$491.8k
Bought 37,783 shares
@ $48.93, valued at
$1.8M
Bought 59,787 shares
@ $49.82, valued at
$3M
|
|
| 06/16/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 06/08/2023 |
3
| Cormorant Asset Management, LP (See below) has filed a Form 3 on GreenLight Biosciences Holdings, PBC |
| 04/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 400,000 shares
@ $30, valued at
$12M
|
|
| 03/31/2023 |
SC 13G
| Chen Bihua reports a 17.6% stake in MoonLake Immunotherapeutics |
| 03/22/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 446,881 shares
@ $19.3639, valued at
$8.7M
Bought 63,700 shares
@ $20.4207, valued at
$1.3M
Bought 78,008 shares
@ $21.0836, valued at
$1.6M
Bought 238,511 shares
@ $21.7013, valued at
$5.2M
|
|
| 03/16/2023 |
4
| Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Bought 250,000 shares
@ $9.9531, valued at
$2.5M
Bought 250,000 shares
@ $10.5955, valued at
$2.6M
Bought 500,000 shares
@ $10.1485, valued at
$5.1M
|
|
| 03/13/2023 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Ambrx Biopharma Inc. |
| 02/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 12/21/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 04/07/2022 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Converted 2,785,000 shares
@ $0
Bought 2,850,000 shares
@ $10, valued at
$28.5M
Converted 2,785,000 options to buy
@ $0 |
|
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 01/13/2022 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Converted 616,786 shares
@ $0
Converted 616,786 convertible preferred
@ $0 |
|
| 01/06/2022 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 11/15/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 10/27/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Converted 785,303 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 548,288 convertible preferred
@ $0
Converted 237,015 convertible preferred
@ $0 |
|
| 10/20/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Ventyx Biosciences, Inc. |
| 10/15/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Converted 668,854 shares
@ $0
Bought 450,000 shares
@ $16, valued at
$7.2M
Converted 668,854 convertible preferred
@ $0 |
|
| 10/07/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Pyxis Oncology, Inc. |
| 09/21/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Converted 757,432 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 757,432 convertible preferred
@ $0 |
|
|
|
|